<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2176</journal-id>
<journal-title><![CDATA[Revista Cubana de Oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Oftalmol]]></abbrev-journal-title>
<issn>0864-2176</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21762020000400008</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfermedades sistémicas y glaucoma]]></article-title>
<article-title xml:lang="en"><![CDATA[Systemic diseases and glaucoma]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Obret Mendive]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz Águila]]></surname>
<given-names><![CDATA[Yuderkys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Acosta]]></surname>
<given-names><![CDATA[Lizet]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cárdenas Chacón]]></surname>
<given-names><![CDATA[Daylin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fumero González]]></surname>
<given-names><![CDATA[Francisco]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Cubano de Oftalmología "Ramón Pando Ferrer"  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>33</volume>
<numero>4</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21762020000400008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21762020000400008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21762020000400008&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN El glaucoma, considerado el ladrón silencioso de la visión, es la segunda causa de ceguera irreversible en el mundo. A pesar de los avances científicos y tecnológicos no se ha encontrado una cura definitiva para esta enfermedad. Lo más evidente ha sido el control adecuado de los valores de presión intraocular para evitar la progresión del daño del nervio óptico y sus consecuencias en el campo visual, así como la ceguera irreversible. En muchas ocasiones logramos tener la presión intraocular en valores óptimos y aun así la enfermedad avanza, por lo que nos preguntamos qué falló y por qué sucede. No podemos olvidar que el nervio óptico no es lo único que se altera en esta patología; existe evidencia de que se extiende de las células ganglionares de la retina al cuerpo geniculado lateral y a la corteza visual en los hemisferios cerebrales. Ante fenómenos de espasmo, isquemia o bajo flujo, se desencadenan reacciones bioquímicas, estrés oxidativo y otras situaciones que contribuyen al desarrollo de esta neuropatía. Con el objetivo de evaluar con mayor profundidad a los pacientes glaucomatosos, se realizó una revisión sobre la influencia de las más frecuentes enfermedades sistémicas en la neuropatía óptica glaucomatosa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Glaucoma, also known as the "silent thief of sight", is the second leading cause of irreversible blindness worldwide. Despite the scientific and technological advances achieved in the field, a definitive cure has not been found for this disease. The most evident achievement so far has been the adequate control of intraocular pressure values to prevent the progress of optic nerve damage and its effects on the visual field, as well as irreversible blindness. On many occasions it has been possible to maintain intraocular pressure at optimal values, and even then the disease continues to advance, making us wonder what went wrong and why this happens. It should not be forgotten that the optic nerve is not the only organ affected by this condition. There is evidence that damage extends from retinal ganglion cells to the lateral geniculate body and the visual cortex in cerebral hemispheres. Spasm, ischemia or low flow phenomena trigger biochemical reactions, oxidative stress and other processes contributing to the development of this neuropathy. With the purpose of evaluating glaucoma patients in greater depth, a review was conducted about the influence of a number of very common systemic diseases on glaucomatous optic neuropathy.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Presión intraocular]]></kwd>
<kwd lng="es"><![CDATA[nervio óptico]]></kwd>
<kwd lng="es"><![CDATA[glaucoma]]></kwd>
<kwd lng="es"><![CDATA[neuropatía]]></kwd>
<kwd lng="en"><![CDATA[Intraocular pressure]]></kwd>
<kwd lng="en"><![CDATA[optic nerve]]></kwd>
<kwd lng="en"><![CDATA[glaucoma]]></kwd>
<kwd lng="en"><![CDATA[neuropathy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barría]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez Román]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Latin american guide to primary open angle glaucoma for the general ophthalmologist]]></source>
<year>2019</year>
<publisher-name><![CDATA[Organización Panamericana de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sarwat]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bruce Shields]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glaucoma and Systemic Diseases]]></article-title>
<source><![CDATA[Surv Ophthalmol]]></source>
<year>2010</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>64-77</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Melgarejo]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Petitto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yépez]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Murati]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glaucomatous Optic Neuropathy Associated with Nocturnal Dip in Blood Pressure]]></article-title>
<source><![CDATA[Ophthalmology]]></source>
<year>2018</year>
<volume>125</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>807-14</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bao]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperlipidemia, blood lipid level, and the risk of glaucoma A Meta-Analysis]]></article-title>
<source><![CDATA[Invest Ophthalmol Vis Sci]]></source>
<year>2019</year>
<volume>60</volume>
<page-range>1028-43</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Talwar]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Musch]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of daily dosage and type of statin agent with risk of open-angle glaucoma]]></article-title>
<source><![CDATA[JAMA Ophthalmol]]></source>
<year>2017</year>
<volume>135</volume>
<page-range>263-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[YC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between statin use and open-angle glaucoma in hyperlipidemia patients: a Taiwanese population-based case-control study]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2015</year>
<volume>94</volume>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of statin use and high serum cholesterol levels with risk of primary open-angle glaucoma]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Boumenna]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Khawaja]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rosner]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Wiggs]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Pasquale]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA Ophthalmol.]]></source>
<year>2019</year>
<volume>137</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>756-65</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xiao]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Gong]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of statins and risk of reducing glaucoma Is There a Link]]></article-title>
<source><![CDATA[Med Princip Pract]]></source>
<year>2017</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>296</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weiming]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association between adiposity and the risk of glaucoma: a meta-analysis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Jiawen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ch]]></surname>
<given-names><![CDATA[Yiyi]]></given-names>
</name>
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Peirong]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Hind J Ophthalmol]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bülent]]></surname>
<given-names><![CDATA[Ç]]></given-names>
</name>
<name>
<surname><![CDATA[Iclal ErdEm]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tugrul]]></surname>
<given-names><![CDATA[Ç]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of obesity on retrobulbar flow hemodynamics: color Doppler ultrasound evaluation]]></article-title>
<source><![CDATA[Arq Bras Oftalmol]]></source>
<year>2017</year>
<volume>80</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>143-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[WW]]></given-names>
</name>
<name>
<surname><![CDATA[Shie]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between peripheral vascular endothelial function and progression of open-angle glaucoma]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2016</year>
<volume>95</volume>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vajaranant]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Pasquale]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estrogen de ciency accelerates aging of the optic nerve]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2012</year>
<volume>19</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>942-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seyed Ahmad]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Mahdi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Negin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Maryam]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mohammad]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association between primary open angle glaucoma and clustered components of metabolic syndrome]]></article-title>
<source><![CDATA[Open Ophthalmol J]]></source>
<year>2015</year>
<volume>9</volume>
<page-range>149-55</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yokomichi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Kashiwagi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kitamura]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the associations between changes in intraocular pressure and metabolic syndrome parameters: a retrospective cohort study in Japan]]></article-title>
<source><![CDATA[BMJ Open]]></source>
<year>2016</year>
<volume>6</volume>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[JunSeok]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[HyunMin]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[JunHyuk]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association between intraocular pressure and different combination of metabolic syndrome components]]></article-title>
<source><![CDATA[BMC Ophthalmol]]></source>
<year>2016</year>
<volume>16</volume>
<page-range>76</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ch]]></surname>
<given-names><![CDATA[Young]]></given-names>
</name>
<name>
<surname><![CDATA[Yun Jin]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sang Yeoup]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Jeong Gyu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ch]]></surname>
<given-names><![CDATA[Byung Mann]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome as a risk factor for high intraocular pressure: the Korea National Health and Nutrition Examination Survey 2008-2010]]></article-title>
<source><![CDATA[Diabetes, Metabolic Syndrome and Obesity. Targ Ther]]></source>
<year>2019</year>
<volume>12</volume>
<page-range>131-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Younhea]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kyungdo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hae-Young]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chan Kee]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic health, obesity, and the risk of developing open-angle glaucoma: metabolically healthy obese patients versus metabolically unhealthy but normal weight patients]]></article-title>
<source><![CDATA[Diab Metab J]]></source>
<year>2019</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>414-25</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yi-Xin]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Jian-Xin]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Yong]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association of intraocular pressure with metabolic syndrome and its components a Meta-analysis and systematic review]]></article-title>
<source><![CDATA[Int J Ophthalmol]]></source>
<year>2019</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>510-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiasseu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tau Accumulation, Altered Phosphorylation and Missorting Promote Neurodegeneration in Glaucoma]]></article-title>
<source><![CDATA[J. Neurosci]]></source>
<year>2016</year>
<volume>36</volume>
<page-range>5785-98</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elevated intraocular pressure induces amyloid-beta deposition and tauopathy in the lateral geniculate nucleus in a Monkey model of glaucoma]]></article-title>
<source><![CDATA[Invest Ophthalmol]]></source>
<year>2017</year>
<volume>58</volume>
<page-range>5434-43</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jong Youn]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hyung Jun]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Yoon Hyung]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Tae Kwann]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Eun-Cheol]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Chan Yun]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between open-angle glaucoma and the risks of Alzheimer's and Parkinson's diseases in South Korea A 10-year Nationwide Cohort Study]]></article-title>
<source><![CDATA[SCIeNtIfIC RePOrtS]]></source>
<year>2018</year>
<volume>8</volume>
<page-range>11161</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Yuan-Hung]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Tsung-Jen]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glaucoma, Alzheimer's disease, and]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Sh]]></surname>
<given-names><![CDATA[Yun-Den]]></given-names>
</name>
<name>
<surname><![CDATA[Ch]]></surname>
<given-names><![CDATA[Nai-Fang]]></given-names>
</name>
<name>
<surname><![CDATA[Ch]]></surname>
<given-names><![CDATA[Li-Nien]]></given-names>
</name>
</person-group>
<source><![CDATA[Parkinson's disease: An 8-Year population-based follow-up study]]></source>
<year>2014</year>
<volume>9</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Merel]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Sabine]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Klaus]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Werner]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Nienke]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Parkins Rel Disord]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancino]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martucci]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cesareo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Giannini]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Corasaniti]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Bagetta]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glaucoma and Alzheimer Disease One Age-Related Neurodegenerative Disease of the Brain]]></article-title>
<source><![CDATA[Curr Neuropharm]]></source>
<year>2018</year>
<volume>16</volume>
<page-range>971-7</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colligris]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez de Lara]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Colligris]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Pintor]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular manifestations of Alzheimer's and other neurodegenerative diseases: The prospect of the eye as a tool for the early diagnosis of Alzheimer's disease]]></article-title>
<source><![CDATA[Hind J Ophthalmol]]></source>
<year>2018</year>
<numero>2018</numero>
<issue>2018</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
